An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program (2003) / Chapter Skim
Currently Skimming:
6 Proposed Studies on the Acceptability of the Anthrax Vaccine
6 Proposed Studies on the Acceptability of the Anthrax Vaccine
Pages 82-90
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 82... ...
A study in Air National Guard and Air Force Reserve forces indicated that the level of concern about AVA was high (GAO, 20001. Similarly, a CDC pilot study of vaccine providers and health care administrators at an Air Force base in August 2000 found that 20 percent of the respondents were concerned about the safety of the vaccine and that only ~ 5 percent believed they were likely to be exposed to anthrax spores (CDC, 2002a)
|
From page 83... ...
HI I ~E(~1 Ed off dssessm~ tools. Debiled dock of He acc~t~iliV of Be vaccine within Me Elite Paul is Be maw East of Be research prows as plied.
|
From page 84... ...
SllRVE:Y OF KNOWLEDGE, ATTITUDES, AND BEL.lEFS REGARDING TEE ANTHRAX VACCINE AMONG MILITARY PERSONNEL The stated goal for this portion of CDC's research on the acceptability of the anthrax vaccine is to assess the KABs of military service and health care personnel regarding AVA (CDC, 2002a,6~. Representative surveys of the military population are planned for two different time points to provide an understanding of the factors influencing perceptions of the safety and efficacy of the anthrax vaccine and to direct the development of appropriate educational materials.
|
From page 85... ...
Focus groups in phase ~ of the study design are further subdivided into phase lA and phase IB. Phase lA focus groups will be used to gather information that can be applied to the development of the survey for phase ~ of the study, as well as to explore the KABs of military personnel regarding their sources of information about AVA and the perceived credibility of these sources.
|
From page 86... ...
The testing to validate the survey instrument will include preliminary cognitive testing interviews; a pilot study for each of the active services, a National Guard unit, and a reserve unit; and a psychometric analysis test. Six questions from the Balanced Inventory of Desirable Responding (BIDR)
|
From page 87... ...
Finding: With its large sample size, the current design of the study of knowledge, attitudes, anal beliefs regarding AVA primarily addresses the acceptability of the vaccine among military personnel. Further documentation of the prevalence of attitudes and beliefs regarding the vaccine is unlikely to significantly advance the acceptability of the vaccine, which should be the major goal.
|
From page 88... ...
In the first phase, RTI will recruit military and civilian health care providers from selected sites in eight geographically diverse areas to ensure multiple viewpoints. The focus groups will be used to collect qualitative data from health care providers about reporting of adverse events to VAERS following immunization.
|
From page 89... ...
Recommendation: In addition to gathering information on KABs about VAERS and the current anthrax vaccine, CDC should modify the survey of health care providers to study KABs about a new anthrax vaccine, other military vaccines, and vaccines in general, with a focus on information useful for timely development and testing of appropriate educational materials. The study population should include health care providers who may treat service members with adverse events following vaccination as well as those who administer vaccines.
|
From page 90... ...
2002e. Section 10: study summary: survey of civilian and military healthcare providers regarding the anthrax vaccine and the reporting of possible vaccine-associated adverse events.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.